Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Guardion Health Sciences Announces Financial Results for the Three Months and Six Months Ended June 30, 2024
-
Golar LNG Limited: 2024 AGM Results Notification
-
Beam Global Announces Record Second Quarter 2024 Operating Results
-
Inspirato Announces Second Quarter Results and Closing of $10 Million Investment Agreement with One Planet Group LLC
-
BioCardia Reports Second Quarter 2024 Business Highlights and Financial Results
-
Sutro Biopharma Reports Second Quarter 2024 Financial Results, Business Highlights and Select Anticipated Milestones
-
Syntec Optics (Nasdaq: OPTX) to Host Conference Call to Discuss Financial Results and Business Update
-
Springbig Reports Second Quarter 2024 Financial Results
-
Elicio Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Updates
-
KashKick is the 11th-Fastest Growing US Company on Inc Magazine’s Prestigious Annual 5000 List for 2024
-
Cidara Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results
-
Auburn National Bancorporation, Inc. Declares Quarterly Dividend
-
CytoSorbents Reports Second Quarter 2024 Financial and Operational Results
-
Navient to sell Healthcare Services business to CorroHealth as part of ongoing plan to simplify company
-
CytoSorbents Appoints Peter J. Mariani Chief Financial Officer
-
Bavarian Nordic Receives Order from HERA and Announces Significant Donation of Vaccines in Response to the Mpox Outbreak in Africa
-
CPI Aerostructures Reports Second Quarter and Six Month 2024 Results
-
Vishay Intertechnology Declares Quarterly Dividend
-
Duos Technologies Group Reports Second Quarter 2024 Results
-
Panbela Provides Business Update and Reports Q2 2024 Financial Results
-
John B. Sanfilippo & Son, Inc. 4th Quarter and Full-Year 2024 Operating Results Conference Call
-
Cheetah Net Supply Chain Service Inc. Announces Second Quarter 2024 Results and Provides Corporate Update
-
SELLAS Life Sciences Reports Second Quarter 2024 Financial Results and Provides Corporate Update
-
Ibotta Reports Second Quarter 2024 Financial Results
-
John B. Sanfilippo & Son, Inc. 4th Quarter and Full-Year 2024 Operating Results Conference Call
-
Solid Biosciences Reports Second Quarter 2024 Financial Results and Provides Business Updates
-
Key Tronic Corporation Announces Results for the Fourth Quarter of Fiscal Year 2024
-
UPDATE -- Firefly Neuroscience CEO Issues Letter to Stockholders Following Closing of Merger and Listing on Nasdaq
-
Conifex Announces Second Quarter 2024 Results
-
Fortress Biotech Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights
-
Glass House Brands Reports Record Setting Second Quarter 2024 Financial Results
-
Jones Soda Reports Second Quarter 2024 Results
-
ANI Pharmaceuticals, Inc. Closes $316.25 Million Convertible Senior Notes Offering Including Full Exercise of Initial Purchasers’ Option to Purchase Additional Notes
-
Senti Bio Announces Second Quarter 2024 Results and Reviews Recent Corporate and Pipeline Highlights
-
Alumis Reports Second Quarter 2024 Financial Results and Highlights Recent Development and Corporate Achievements
-
LogicMark, Inc. Announces Second Quarter 2024 Financial Results; Expansion Strategy into Personal Safety Markets Continues
-
Psychemedics Corporation Reports Second Quarter 2024 Financial Results
-
CNB Financial Corporation Announces Quarterly Dividend for Common Stock
-
Trinity Biotech to Announce Q2 2024 Financial Results
-
Dyadic Announces Second Quarter 2024 Financial Results and Highlights Recent Company Progress
-
Global Crossing Airlines Reports Second Quarter 2024 Financial Results
-
NeuroPace Reports Second Quarter 2024 Financial Results and Increases 2024 Revenue Guidance
-
Reed’s Reports Second Quarter 2024 Results
-
Schwazze Announces Second Quarter 2024 Financial Results
-
Mineralys Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update
-
ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2024
-
Tenax Therapeutics Reports Second Quarter 2024 Financial Results and Provides a Corporate Update
-
Zevra Therapeutics Reports Second Quarter 2024 Financial Results and Corporate Highlights
-
Xos, Inc. delivers strong unit delivery, sales growth and promising operating profit performance in the second quarter of 2024
-
Epsilon Reports Second Quarter 2024 Results

